The OVA1-test, for example, combines five proteins (Apolipoprotein A1, Beta 2 microglobulin, MUCIN-16, Transferrin and Prealbumin/Transthyretin) and is used to divide women into groups with high, intermediate, or low risk of ovarian cancer. Here, TTR is linked to ovarian carcinoma.